13F Data
13F filer · CIK 1855655

Paradigm Biocapital Advisors LP

NEW YORK, NY · filing since Q4 2021 · last filing Aug 14, 2026
Reported value
$5.3B
+$446.3M vs prior
Positions
28
New / sold out
7 / 14
Added / reduced
12 / 7
Turnover
23.1%
buys $1.2B · sells $1.7B
Top-10 weight
75.2%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedSPYRE THERAPEUTICS INC+1,883,512+96.2%+$167.2M
NewALNYLAM PHARMACEUTICALS INC+480,000–+$144.5M
AddedGENMAB A/S+5,165,295+64.8%+$141.9M
NewMBX BIOSCIENCES INC+2,508,015–+$138.4M
AddedEDGEWISE THERAPEUTICS INC+2,850,417+38.7%+$115.8M
AddedNUVALENT INC+600,000+11.3%+$74.1M
AddedTANGO THERAPEUTICS INC+2,347,844+58.6%+$73.4M
AddedVIRIDIAN THERAPEUTICS INC+3,574,895+113.5%+$65.7M
NewJADE BIOSCIENCES INC+2,857,405–+$63.5M
NewACHIEVE LIFE SCIENCE INC+4,951,856–+$32.3M
9 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outARCELLX INC-5,774,016-100.0%$-663.0M
ReducedVAXCYTE INC-2,665,168-55.6%$-154.9M
Sold outCENTESSA PHARMACEUTICALS PLC-3,574,048-100.0%$-142.0M
Sold outTERNS PHARMACEUTICALS INC-2,216,499-100.0%$-116.9M
Sold outCYTOKINETICS INC-1,480,857-100.0%$-97.6M
Sold outABIVAX SA-772,473-100.0%$-86.0M
Sold outMAZE THERAPEUTICS INC-2,744,399-100.0%$-81.9M
Sold outSCHOLAR ROCK HLDG CORP-1,226,080-100.0%$-60.3M
Sold outMIRUM PHARMACEUTICALS INC-625,000-100.0%$-57.7M
ReducedREVOLUTION MEDICINES INC-294,380-4.4%$-55.1M
11 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2021: $350.2MQ1 2022: $378.2MQ2 2022: $501.5MQ3 2022: $750.1MQ4 2022: $851.9MQ1 2023: $1.1BQ2 2023: $1.3BQ3 2023: $1.5BQ4 2023: $2.1BQ1 2024: $2.8BQ2 2024: $2.6BQ3 2024: $3.0BQ4 2024: $2.9BQ1 2025: $2.2BQ2 2025: $2.3BQ3 2025: $3.5BQ4 2025: $3.9BQ1 2026: $4.9BQ2 2026: $5.3B
Q4 2021Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1REVOLUTION MEDICINES INCCOM6,361,323$1.2B22.31%
2NUVALENT INCCOM5,924,433$731.7M13.70%
3EDGEWISE THERAPEUTICS INCCOM10,215,455$415.1M7.77%
4GENMAB A/SSPONSORED ADS13,133,131$360.8M6.76%
5SPYRE THERAPEUTICS INCCOM NEW3,840,778$341.0M6.38%
6APOGEE THERAPEUTICS INCCOM1,576,385$209.2M3.92%
7ORUKA THERAPEUTICS INCCOM2,144,526$204.1M3.82%
8TANGO THERAPEUTICS INCCOM6,357,523$198.7M3.72%
9BELITE BIO INCSPONSORED ADS1,232,877$189.8M3.55%
10ERASCA INCCOM9,550,000$175.0M3.28%
18 more rows. Subscribe for $29/month to see every row, download the data and use the API.